P

Inventor

GOEDDEL DAVID V

US91 patents
⚠️ This page may combine multiple inventors who share the name “GOEDDEL DAVID V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

38 patents
US4766075AAug 23, 1988

Human tissue plasminogen activator

GENENTECH INC298 citations99
US4727138AFeb 23, 1988

Human immune interferon

GENENTECH INC150 citations99
US4678751AJul 7, 1987

Hybrid human leukocyte interferons

GENENTECH INC187 citations99
US5736135AApr 7, 1998

Method for making variant secreted proteins with altered properties

GENENTECH INC123 citations97
US5223408AJun 29, 1993

Method for making variant secreted proteins with altered properties

GENENTECH INC321 citations97
US4762791AAug 9, 1988

Human immune interferon

GENENTECH INC124 citations97
US4601980AJul 22, 1986

Microbial expression of a gene for human growth hormone

GENENTECH INC74 citations97
US4342832AAug 3, 1982

Method of constructing a replicable cloning vehicle having quasi-synthetic genes

GENENTECH INC131 citations97
US5795745AAug 18, 1998

Human growth hormone

GENENTECH INC42 citations96
US5582824ADec 10, 1996

Recombinant DES-CYS-TYR-CYS human immune interferon

GENENTECH INC55 citations96
US5424199AJun 13, 1995

Human growth hormone

GENENTECH INC67 citations96
US5096705AMar 17, 1992

Human immune interferon

GENENTECH INC64 citations96
US4925793AMay 15, 1990

Human immune interferon

GENENTECH INC60 citations96
US4898830AFeb 6, 1990

Human growth hormone DNA

GENENTECH INC52 citations96
US4658021AApr 14, 1987

Methionyl human growth hormone

GENENTECH INC63 citations96
US4634677AJan 6, 1987

Plasmid capable of expressing human growth hormone

GENENTECH INC55 citations96
US4604359AAug 5, 1986

Microbial expression of a gene for human growth hormone

GENENTECH INC48 citations96
US4456748AJun 26, 1984

Hybrid human leukocyte interferons

GENENTECH INC71 citations96
US4414150ANov 8, 1983

Hybrid human leukocyte interferons

GENENTECH INC118 citations96
US5200176AApr 6, 1993

Method for protection of ischemic tissues using tumor nerosis factor

GENENTECH INC59 citations95
US4886747ADec 12, 1989

Nucleic acid encoding TGF-β and its uses

GENENTECH INC115 citations95
US4742003AMay 3, 1988

Human transforming growth factor

GENENTECH INC110 citations95
US5831023ANov 3, 1998

Recombinant animal interferon polypeptides

GENENTECH INC29 citations93
US5789550AAug 4, 1998

TRAF inhibitors

GENENTECH INC25 citations93
US5708142AJan 13, 1998

Tumor necrosis factor receptor-associated factors

GENENTECH INC17 citations93
US5670319ASep 23, 1997

Assay for tumor necrosis factor receptor-associated factors

GENENTECH INC26 citations93
US5460811AOct 24, 1995

Mature human fibroblast interferon

GENENTECH INC42 citations93
US5231176AJul 27, 1993

Distinct family DNA encoding of human leukocyte interferons

GENENTECH INC64 citations93
US5185259AFeb 9, 1993

Truncated human tissue plasminogen activator

GENENTECH INC25 citations93
US4853330AAug 1, 1989

Human tissue plasminogen activator

GENENTECH INC49 citations93
US5801231ASep 1, 1998

Nucleic acid encoding TGF-β and its uses

GENENTECH INC24 citations92
US5352587AOct 4, 1994

Compositions and methods for the synthesis of natriuretic protein receptor B and methods of use

GENENTECH INC43 citations92
US6673343B2Jan 6, 2004

SAL-S1 receptor protein tyrosine kinase agonist antibodies

GENENTECH INC38 citations91
US5284763AFeb 8, 1994

Nucleic acid encoding TGF-β and its uses

GENENTECH INC53 citations91
US5120832AJun 9, 1992

Distinct family of human leukocyte interferons

GENENTECH INC41 citations89
US5869314AFeb 9, 1999

Tissue plasminogen activators and derivatives thereof as produced by recombinant means

GENENTECH INC8 citations82
US5753486AMay 19, 1998

Human tissue plasminogen activator

GENENTECH INC8 citations82
US5587159ADec 24, 1996

Human tissue plasminogen activator

GENENTECH INC9 citations82

TULARIK INC

8 patents

HOFFMANN LA ROCHE

3 patents

GOEDDEL DAVID V

1 patent

Showing the top 50 of 91 patents by PatentIndex Score.